TotalMarketCap

Vertex Pharmaceuticals

VRTXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$127.554 B

$503.25 -0.47%

Close of 9 Oct 2026

As of 9 Oct 2026, Vertex Pharmaceuticals (VRTX) has a market capitalization of $127.6B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$12.0B

#367 by revenue

Earnings

$3.95B

#127 by earnings

Shares outstanding

253,460,924

Latest filing cover page

P/E ratio

32.3

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 500 →
  1. #8Novo Nordisk A SNVO$169.1B
  2. #9PfizerPFE$158.6B
  3. #10Vertex PharmaceuticalsVRTX$127.6B
  4. #11Bristol Myers SquibbBMY$121.7B
  5. #12SanofiSNY$98.1B

What if Vertex Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $29.1T

$114,660.10

Per share 228× higher

Bitcoin $1.66T

$6,551.62

Per share 13.0× higher

Nvidia $5.55T

$21,914.89

Per share 43.5× higher

Or at a round number

$200.0B$500.0B$1.00T$2.00T

Where these numbers come from

Share counts and financials for Vertex Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 10 Oct 2026. Read the methodology.